Full Text:   <1809>

Summary:  <10>

CLC number: 

On-line Access: 2020-03-01

Received: 2019-10-18

Revision Accepted: 2020-01-22

Crosschecked: 2020-03-01

Cited: 0

Clicked: 2152

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Bio-Design and Manufacturing  2020 Vol.3 No.1 P.7-14

http://doi.org/10.1007/s42242-020-00060-0


Design and strategy for manufacturing kidney organoids


Author(s):  Masaki Nishikawa, Yasuyuki Sakai, Norimoto Yanagawa

Affiliation(s):  Department of Chemical System Engineering, School of Engineering, University of Tokyo, Rm. 5A01, Engineering Bldg. 3, Hongo 7-3-1, Bunkyo, Tokyo 113-8656, Japan; more

Corresponding email(s):   masaki@chemsys.t.u-tokyo.ac.jp

Key Words:  Kidney organoid, Kidney development, iPSC, Progenitor cell, Self-organization, Regenerative medicine


Share this article to: More

Masaki Nishikawa, Yasuyuki Sakai, Norimoto Yanagawa. Design and strategy for manufacturing kidney organoids[J]. Journal of Zhejiang University Science D, 2020, 3(1): 7-14.

@article{title="Design and strategy for manufacturing kidney organoids",
author="Masaki Nishikawa, Yasuyuki Sakai, Norimoto Yanagawa",
journal="Journal of Zhejiang University Science D",
volume="3",
number="1",
pages="7-14",
year="2020",
publisher="Zhejiang University Press & Springer",
doi="10.1007/s42242-020-00060-0"
}

%0 Journal Article
%T Design and strategy for manufacturing kidney organoids
%A Masaki Nishikawa
%A Yasuyuki Sakai
%A Norimoto Yanagawa
%J Journal of Zhejiang University SCIENCE D
%V 3
%N 1
%P 7-14
%@ 1869-1951
%D 2020
%I Zhejiang University Press & Springer
%DOI 10.1007/s42242-020-00060-0

TY - JOUR
T1 - Design and strategy for manufacturing kidney organoids
A1 - Masaki Nishikawa
A1 - Yasuyuki Sakai
A1 - Norimoto Yanagawa
J0 - Journal of Zhejiang University Science D
VL - 3
IS - 1
SP - 7
EP - 14
%@ 1869-1951
Y1 - 2020
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1007/s42242-020-00060-0


Abstract: 
Despite a continuing increase in the number of patients sufering from chronic kidney disease, currently available treatments for these patients, such as dialysis and kidney transplantation, are imperfect. The kidney is also a critical target organ vulnerable to the toxicity of various new drugs, and the lack of a reliable in vitro culture model imposes a severe limitation on drug discovery. Although the development of induced pluripotent stem cells (iPSCs) revolutionized strategies in biomedical felds, the complexity of the kidney imposed additional challenge to the application of this technology in kidney regeneration. Nonetheless, the recent advancement in our understanding on the developmental origin of kidney progenitor cells and the mechanisms of their reciprocal induction and self-organization has boosted research in kidney regeneration. Research since then has demonstrated that kidney organoids derived from iPSCs can serve as a useful model for drug discovery and toxicity screening, as well as for disease modeling, especially in combination with gene editing techniques. Moreover, attempts at kidney organoid implantation in animals have suggested their potential as an alternative source of kidney transplantation. In this review, we summarize recent progress on the generation of kidney organoids, as well as the obstacles that remain.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE